Database for robotic-assisted prostate cancer surgeries
National Robotics-Assisted Radical Prostatectomy Database: Exploring Learning Curves and Long Term Surgical, Oncological and Patient Reported Outcome Measures (PROMS)
This study is gathering information from hospitals to see how well robotic surgeries for prostate cancer work and how they compare to traditional surgeries for patients in Australia.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | Male |
| Sponsor | Melbourne Health Academic / other |
| Locations | 8 sites (Ballarat, Victoria and 7 other locations) |
| Trial ID | NCT06279260 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive database to analyze the long-term outcomes of robotic-assisted radical prostatectomy (RARP) for patients diagnosed with localized prostate cancer in Australia. It will gather data from multiple hospitals to assess the effectiveness, complications, and overall patient experiences associated with robotic surgeries compared to traditional methods. The study seeks to address the current lack of large-scale data on RARP outcomes and the factors influencing surgical success. By compiling this information, the study hopes to provide insights that could improve surgical practices and patient care.
Who should consider this trial
Good fit: Ideal candidates for this study are men aged 18 to 90 years with a confirmed diagnosis of localized prostate cancer who are undergoing robotic-assisted prostatectomy.
Not a fit: Patients who have not undergone robotic surgery or do not have a diagnosis of prostate cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and better-informed decisions regarding prostate cancer treatment options for patients.
How similar studies have performed: While smaller studies have shown promising results for robotic-assisted surgeries, this large-scale database approach is novel and aims to provide more generalized insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: To be eligible to participate in this database, an individual must meet all of the following criteria: 1. Individuals who consent to participate, 2. within the age range of 18 to 90 years, 3. confirmed diagnosis of localized prostate cancer (PCa) 4. patients receiving medical attention at hospitals engaged in collaborative efforts with the designated database. Exclusion Criteria: 1. Participants are not eligible to take part in the database: 2. Individuals who have not undergone robotic surgery for prostatectomy or TP biopsy. , 3. without a diagnosis of prostate cancer or 4. who decline to provide consent for the collection of their health information 5. Under the age of 18 years.
Where this trial is running
Ballarat, Victoria and 7 other locations
- Ballarat Health — Ballarat, Victoria, Australia (Not_yet_recruiting)
- Barwon health — Geelong, Victoria, Australia (Not_yet_recruiting)
- Austin Healthcare — Melbourne, Victoria, Australia (Not_yet_recruiting)
- E.J Whitten Prostate Cancer Centre, Epworth Healthcare — Melbourne, Victoria, Australia (Not_yet_recruiting)
- St. Vincent's Private Hospital — Melbourne, Victoria, Australia (Not_yet_recruiting)
- Western Heath — Melbourne, Victoria, Australia (Not_yet_recruiting)
- Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia (Not_yet_recruiting)
- Royal Melbourne Hospital — Melbourne, Victoria, Australia (Recruiting)
Study contacts
- Study coordinator: Nathan Lawrentschuk, MBBS,PhD, FRACS
- Email: lawrentschuk@gmail.com
- Phone: +6193291197
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.